Release Date: 20/01/16 10:23 Summary: Ferrovial - Second Supplementary Bidder's Statement Price Sensitive: Yes Download Document 456.91KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%